Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Synthego adopts GMP standards for producing sgRNA

Synthego has adopted Good Manufacturing Practice standards for producing customized GMP-grade synthetic guide RNA at its facilities, an initiative the company said will benefit its academic and industry customers as they develop advanced cell and gene therapies.

From Synthego Corporation 23 Jan 2020

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line to NGM Biopharmaceuticals, Inc..

From Revvity 22 Jan 2020

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system.

22 Jan 2020

New approach for the manufacture of Advanced Therapy Medicinal Products

Akron Biotechnology has proposed a new approach for the qualification of ancillary materials for the manufacture of Advanced Therapy Medicinal Products.

22 Jan 2020

New achievement with 3D-printing could have applications in pharmaceutical industry

University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilized gold with biodegradable and biocompatible systems that have been obtained with 3D-printng techniques.

17 Jan 2020

NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

Cardiovascular disease, including heart disease and stroke, are among the top killers worldwide. Ischemic heart disease and stroke are the world’s major killers, accounting for 15.2 million deaths in 2016. A high triglyceride level, combined with high low-density lipoprotein (LDL) cholesterol, is linked to atherosclerosis, which increases the risk for heart attack and stroke.

16 Jan 2020

OU collaborates with Peruvian University to develop $9 million joint research program

The University of Oklahoma has entered an agreement to develop a $9 million program of joint research with Universidad Nacional de San Agustin, one of Peru's largest and oldest public research universities.

16 Jan 2020

Advanced BioMatrix acquires HyStem products for R&D market

Advanced BioMatrix has acquired the HyStem line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan.

16 Jan 2020

New tool could speed up neuroscience research into pheromones

Researchers at Worcester Polytechnic Institute have developed a tool to identify molecular receptors in worms that are involved in sensing pheromones related to mating, an advance that could speed up neuroscience research into pheromones by eliminating months of work.

14 Jan 2020

Evonetix and imec partner to increase production of chip-based technology for desktop DNA platform

EVONETIX LTD, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at a commercial scale.

14 Jan 2020

Top-up funding awarded to 76 ERC grantees to bring frontier research closer to market

Seventy-six top researchers will receive ERC Proof of Concept grants of €150,000 each. This top-up funding is awarded to ERC grantees to explore the innovation potential of their scientific discoveries and bring the results of their frontier research closer to market.

12 Jan 2020

Non-fibrillating form of human insulin could improve treatment for diabetes patients

In a promising discovery that could improve the clinical delivery of insulin for people living with diabetes, scientists have developed a non-fibrillating form of human insulin.

9 Jan 2020

SVC112 molecule acts specifically against head and neck cancer stem cells

The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds.

8 Jan 2020

Single-particle method helps determine isoelectric point of viruses

Viruses are not easy to characterize. But we need to because being able to quickly predict the surface charge of viruses opens up new possibilities for vaccine purification and making gene therapy treatments for eye diseases and muscular dystrophy.

8 Jan 2020

The first clinical trials of CRISPR gene editing have shown promising results

Results of clinical trials testing CRISPR suggest that treating diseases with the gene-editing tool may be on the horizon.

7 Jan 2020

High cost of insulin has life-threatening implications for patients with Type 1 diabetes

The most commonly used forms of insulin cost 10 times more in the U.S. than in any other developed country, according to a commentary in Mayo Clinic Proceedings.

2 Jan 2020

Measuring glycans in samples of antibodies

When Lorna De Leoz invited laboratories to participate in her glycomics study, she hoped for 20 responses. Instead, she was deluged by emails from around the world.

2 Jan 2020

GlobalData: Leading medical robots used by the healthcare industry

The healthcare industry uses four types of robots to improve the current standard of care, according to GlobalData, a leading data and analytics company.

2 Jan 2020

Closing of local automotive assembly plants may lead to rise in opioid overdose deaths

Closing of local automotive assembly plants may lead to increases in deaths from opioid overdose, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Massachusetts General Hospital.

30 Dec 2019

Exposure of pregnant women to persistent organic pollutants linked to smaller fetuses

Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.

30 Dec 2019

Manufacturing News and Research

Further Reading

Synthego adopts GMP standards for producing sgRNA

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

New approach for the manufacture of Advanced Therapy Medicinal Products

New achievement with 3D-printing could have applications in pharmaceutical industry

NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

OU collaborates with Peruvian University to develop $9 million joint research program

Advanced BioMatrix acquires HyStem products for R&D market

New tool could speed up neuroscience research into pheromones

Evonetix and imec partner to increase production of chip-based technology for desktop DNA platform

Top-up funding awarded to 76 ERC grantees to bring frontier research closer to market

Non-fibrillating form of human insulin could improve treatment for diabetes patients

SVC112 molecule acts specifically against head and neck cancer stem cells

Single-particle method helps determine isoelectric point of viruses

The first clinical trials of CRISPR gene editing have shown promising results

High cost of insulin has life-threatening implications for patients with Type 1 diabetes

Measuring glycans in samples of antibodies

GlobalData: Leading medical robots used by the healthcare industry

Closing of local automotive assembly plants may lead to rise in opioid overdose deaths

Exposure of pregnant women to persistent organic pollutants linked to smaller fetuses

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®